Physiological Biomarkers of Cancer Treatment Related Fatigue in Women With Breast Cancer.

This study has been completed.
Sponsor:
Information provided by:
University of New Mexico
ClinicalTrials.gov Identifier:
NCT00277004
First received: January 11, 2006
Last updated: January 6, 2010
Last verified: March 2008
  Purpose

Physiological Biomarkers of Cancer Treatment Related Fatigue in Women with Breast Cancer.


Condition
Breast
Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Physiological Biomarkers of Cancer Treatment Related Fatigue in Women With Breast Cancer.

Resource links provided by NLM:


Further study details as provided by University of New Mexico:

Primary Outcome Measures:
  • Disease Progression [ Time Frame: 3 years ] [ Designated as safety issue: Yes ]

Enrollment: 22
Study Start Date: February 1999
Study Completion Date: March 2005
Primary Completion Date: March 2005 (Final data collection date for primary outcome measure)
Detailed Description:

As above.

  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Females with breast cancer undergoing cancer treatment.

Criteria

Inclusion Criteria:

  • Newly diagnosed early stage breast cancer.

Exclusion Criteria:

  • Not specified.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00277004

Locations
United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 87131
Sponsors and Collaborators
University of New Mexico
Investigators
Principal Investigator: Ian Rabinowitz, MD University of New Mexico
  More Information

No publications provided

Responsible Party: Ian Rabinowitz, MD; Principal Investigator, University of New Mexico - CRTC
ClinicalTrials.gov Identifier: NCT00277004     History of Changes
Other Study ID Numbers: 0399C
Study First Received: January 11, 2006
Last Updated: January 6, 2010
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on April 17, 2014